Employing digital solutions designed to narrow the expertise gap between academic specialty care and real-world practice, Apricity Health is developing candidates for precision management of patients undergoing cancer treatment, The firm's product - ApricityRx⢠- enables intelligent monitoring of patients receiving immune checkpoint therapies. Founded by physician scientists in cancer and immuno-oncology and having an august advisory board of clinical experts led by Nobel Laureate Dr. James Allison, Apricityâs mission is to deliver clinical expertise with digital technology at the point of care to help practicing oncologists and nurses better to manage IO-related toxicities in patients receiving IO therapies. PDTs like ApricityRx have the potential to offer improved efficacy when prescribed in combination with IO medications. About the firm: Apricity was founded by well known physician scientists in the cancer and immuno-oncology area enabled by a seasoned team of AI/ML engineers and guided by an august advisory board of key opinion leaders. With the mission being to make novel life-saving cancer therapies safer, better and more accessible to patients, Apricity is committed to disseminating clinical expertise to benefit patients everywhere, especially those without access to subspecialty ca
